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Stress exposure triggers cognitive and behavioral impairments that inﬂuence decision-making
processes. Decisions under a context of uncertainty require complex reward-prediction
processes that are known to be mediated by the mesocorticolimbic dopamine (DA) system in
brain areas sensitive to the deleterious effects of chronic stress, in particular the orbitofrontal
cortex (OFC). Using a decision-making task, we show that chronic stress biases risk-based
decision-making to safer behaviors. This decision-making pattern is associated with an
increased activation of the lateral part of the OFC and with morphological changes in pyramidal
neurons speciﬁcally recruited by this task. Additionally, stress exposure induces a hypodopa-
minergic status accompanied by increased mRNA levels of the dopamine receptor type 2 (Drd2)
in the OFC; importantly, treatment with a D2/D3 agonist quinpirole reverts the shift to safer
behaviors induced by stress on risky decision-making. These results suggest that the brain
mechanisms related to risk-based decision-making are altered after chronic stress, but can be
modulated by manipulation of dopaminergic transmission.
& 2015 Elsevier B.V. and ECNP. All rights reserved.o.2015.07.003
CNP. All rights reserved.
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Decision-making processes are complex and inﬂuenced by
multiple factors, but can be described as a basic algorithm
consisting of representation, valuation and action selection
1745D2/D3 agonist reverts stress induced risk-aversionsteps, in which computation of the value associated with
each potential action is the determinant element (Rangel
et al., 2008). Research in both animals and humans revealed
that the attribution of value, factoring expectation (the
balance between value and effort) and uncertainty (the
probability of a given outcome), is carried by a network
comprising the medial prefrontal cortex (mPFC) and the
orbitofrontal cortex (OFC), as well as subcortical limbic
regions, including the dorsal striatum and nucleus accum-
bens (Doya, 2008). In addition, manipulations of the dopa-
mine (DA) system, one of the main neurotransmitter
systems modulating mPFC/OFC activity, have also been
shown to impair decision-making processes (Simon et al.,
2009; St Onge et al., 2010; Zeeb et al., 2009), speciﬁcally
those involving behavior under uncertain/risk contexts
(St Onge and Floresco, 2009).
Chronic stress exposure triggers plastic changes in brain
areas involved in valuation and decision-making, including the
prefrontal cortex and the striatum (Cerqueira et al., 2007a).
More importantly, we have also shown that these changes
induced by prolonged stress correlate with altered decision-
making processes, such as a shift from goal-directed to habit-
based choices (Dias-Ferreira et al., 2009) and an impairment
in pavlovian-to-instrumental transfer (Morgado et al., 2012).
However, to the best of our knowledge, no study has
addressed the impact of chronic stress on decisions involving
risk/uncertainty in animals. Thus, in the present study we
used a paradigm in which rats choose between certain (safe)
and uncertain (risky) options, with similar overall expectations
and predictability (Morgado et al., 2014) to assess the impact
of chronic stress exposure on risk-taking behavior. Subse-
quently, we correlated behavioral performance with altera-
tions in the neuronal structure and in the dopaminergic
content of brain regions differentially activated between
stressed and control animals. Finally, we tested whether
treatment with a DA (D2/D3) agonist, quinpirole, was able




The subjects were 126 male Wistar rats (Charles River Laboratories,
Barcelona, Spain), aged 2 months and weighing 250–300 g at the
start of the experiment. The animals were housed in pairs under
standard laboratory conditions (lights on from 8:00 A.M. to 8.00 P.
M.) and had access to food and water ad libitum, except during
behavioral testing, when food was restricted (see below).
All experiments were conducted in accordance with local
regulations (European Union Directive 2010/63/EU) and National
Institutes of Health guidelines on animal care and experimentation
and approved by Direção Geral Veterinária (DGV; the Portuguese
National Institute of Veterinary).
2.2. Experimental workﬂow
The experimental work was divided in two separate experiments
(Fig. 1). In the ﬁrst (Chronic Unpredictable Stress (CUS) vs controls),
80 animals were trained daily in the neutral condition (see below)
for 20 days, until individual performances stabilized. Animals were
then assigned, matching for risk preference on the behavioral task
(controls: 20.9670.83 choices; CUS: 20.5770.85 choices; t=0.33,P=0.74), to be either stressed or serve as controls (40 animals
each). Stress was induced according to the protocol below for 28
days, during which controls were only gently handled three times a
week. The day after this period of stress/handling, 20 animals of
each group had blood collected in the morning for corticosterone
determinations and were sacriﬁced in the afternoon; their brains
were processed as follows: 10 CUS and 10 controls were used for
Golgi reconstructions and the remainder 10 CUS and 10 controls
were macrodissected in ice and used for RT-qPCR and HPLC
analyses. Also the day after the last stress exposure/handling, the
remaining 40 animals (20 controls and 20 CUS), started testing on
the risk-based decision-making task (1 session per day). A subgroup
of these (10 controls and 10 CUS) was sacriﬁced on the same day,
90 min after completing the session (under the neutral condition)
and their brains used for c-fos staining. The other 10 controls and 10
CUS went through the entire paradigm, consisting of 8 days in the
neutral condition, 8 days in the risk-favorable condition and 8 days
in the safe-favorable condition, without interruption. Importantly,
this sequence of conditions was similar for all animals, as previously
described by Morgado et al. (2014). Behavioral analysis only took
into account the last 5 days of each condition, when individual
animal performances were more stable. Each of these 20 animals
was then sacriﬁced 90 min after the last behavioral session and
their brains processed for Golgi-c-fos.
In the second experiment (quinpirole treatment), 46 animals were
ﬁrst trained in the task during 20 days, as above, and subsequently
assigned to one of four groups, matched according to performance on
the behavioral task: controls receiving vehicle, controls receiving
quinpirole, CUS receiving vehicle and CUS receiving quinpirole.
Animals were then handled three times a week (control groups) or
submitted to the CUS protocol for 28 days, after which they were all
tested in 3 consecutive 8-day decision-making paradigms: neutral,
risk-favorable and safe-favorable, as above (1 session/day). Fifteen
minutes before each daily session, throughout the entire period of
testing, animals of the quinpirole groups (controls and stressed)
received ip quinpirole hydrochloride in 0.9% saline (0.15 mg/kg;
Sigma-Aldrich) while the remainder received ip vehicle. Drug dosage
was selected in accordance with previous reports showing behavioral
effects on decision-making tasks (Boulougouris et al., 2009; Kurylo and
Tanguay, 2003) and absence of impact on locomotory parameters
(Morgado et al., 2014). Similarly to experiment 1, and to avoid
interference of the acute effects of quinpirole on behavior (Morgado
et al., 2014), the three ﬁrst days of each paradigm were not
considered for data analysis.2.3. Chronic Unpredictable Stress (CUS)
Animals assigned to the stress group were daily exposed, for 60 min,
to one of ﬁve different stressors: cold water (18 1C), vibration,
restraint, overcrowding and exposure to a hot air stream, randomly
distributed throughout 28 days. This chronic stress paradigm is
considered to better mimic the variability of stressors encountered
in daily life (Sousa et al., 1998). Controls were carefully handled
during the same period.2.4. Biometric parameters
To assess the efﬁcacy of the stress protocol, serum corticosterone
levels of both stressed and control animals were measured the day
after the last stress exposure/handling, in the morning (up to 1 h after
“lights on”). Blood was collected via tail venipuncture, centrifuged at
13,000 rpm for 10 min and serum removed and stored at 80 1C until
use. Serum total corticosteroid levels were measured by radioimmu-
noassay using a commercial kit (R&D Systems, Minneapolis, MN, USA),
according to manufacturer's instructions. The intra- and inter-assay
coefﬁcients of variation were less than 5% and 10%, respectively. The
Figure 1 Experimental outline. Two parallel experiments were conducted. First, the effects of chronic stress on risk-based
decision-making were assessed and a neurochemical, morphological and genetic analysis was performed. Secondly, a dopamine
agonist quinpirole was used to revert the behavioral effects of chronic stress. CUS (Chronic Unpredictable Stress).
P. Morgado et al.1746evolution of the weight of each animal was used as an additional
measure of stress efﬁcacy.2.5. Risk-based decision-making paradigm
Behavioral training and testing was performed in 5-hole operant
chambers (OCs; TSE Systems, Germany) within sound attenuating
cubicles. Each chamber has ﬁve apertures mounted into a wall and a
pellet dispenser in the opposite side to deliver rewards.
The decision-making paradigm was recently described (Morgado
et al., 2014). Each daily session lasted for 30 min or 100 trials,
whichever occurred ﬁrst. In each trial, rats could choose between a
“safe” hole (resulting in the delivery of “s” pellets with 100%
probability) and 4 “uncertain/risk” holes (resulting in the delivery of
“r” pellets with 25% probability), where the number of pellets
rewarded upon each nose-poke in the safe (“s”) or risky (“r”) holes
was manipulated to create three different conditions (neutral s=1 and
r=4, risk favorable s=1 and r=8 and safe favorable s=2 and r=4);
“uncertain/risk” holes, which were randomly allocated, in each trial,
to 4 of the 5 apertures, were illuminated while the “safe” hole was
not. After each choice, animals received reward at the pellet
dispenser, the home cage light was switched off and a new trial
started 5 s later. The total number of trials, the number of choices
(nose-pokes) and omissions (no-nose-poke) and the number of pellets
received in each trial, as well as the total time spent, were
automatically registered by the software. Importantly, this design of
risky and safe choices in the neutral condition evens the overall
outcome of either option, allowing an analysis of risk-taking behaviors
independently of reward value or delay. Of note, the sequence of
paradigms was kept constant across all animals and consisted of an
initial training period in the neutral condition, that lasted for 20 days
and allowed animals to learn the task and reach a baseline perfor-
mance level, followed (after the 28 days of stress/handling) by testing
for 8 days in each of the three conditions: neutral, risk-favorable and
safe-favorable (Morgado et al., 2014).
In order to facilitate motivation for task performance, a food
deprivation regimen (15 g rat chow per day) was initiated 24 h
before behavioral training/testing to maintain the subjects atapproximately 90% of their free-feeding body weight (Dias-
Ferreira et al., 2009; Morgado et al., 2014).
2.6. Dopamine quantiﬁcation by High-Performance
Liquid Chromatography (HPLC)
Following decapitation, brains were rapidly removed and discrete
brain regions, speciﬁcally the OFC and anterior insula, dissected from
the left or the right hemispheres (for HPLC and RT-qPCR in a pseudo-
random, balanced distribution). Animals were anesthetized, decapi-
tated, and heads were immediately snap-frozen in liquid nitrogen.
Brain areas of interest were rapidly dissected on ice under a
stereomicroscope, observing anatomical landmarks. Brieﬂy, serial
sections of the rat brain were collected using a stainless steel brain
matrix (Stoelting Inc, USA; 1.0 mm) and laid down on an ice ﬁlled petri
dish. The anterior insula and orbitofrontal cortex were recognized by
comparing anatomical landmarks with a reference brain atlas (Paxinos
and Watson, 2007). For the anterior insula (4.20 mm to 2.52 mm from
bregma) a rectangular shaped area deﬁned by the claustrum (medial
border) and the cortical surface (lateral border) was deﬁned. The
rhinal ﬁssure deﬁned the lower limit, while the upper tip of the lateral
lining of the claustrum deﬁned the upper limit. For the OFC (5.16 mm
to 4.20 mm from bregma) a triangular shaped area was deﬁned by the
ventral part of the cortex (base), the lateral part of the claustrum
(medial border) and an imaginary line that reﬂected a similar angle to
the base (lateral border). This is easily identiﬁable due to the higher
density of cells that translates in differences of luminescence. The
samples were collected to an Eppendorf and were snap-frozen (dry
ice) and stored at 80 1C until use.
For HPLC, ice-cold samples were homogenized and deproteinized
in 150 μL of 0.2 N perchloric acid solution containing 7.9 mM
Na2S2O5 and 1.3 mM Na2EDTA. The homogenate was centrifuged at
20,000g for 45 min at 4 1C and the supernatant was stored at
80 1C. The analysis was performed by reverse-phase ion pair High-
Performance Liquid Chromatography (HPLC) with an Electrochemi-
cal Detector (ED), as previously described with minor modiﬁcations
(Kyratsas et al., 2013). Speciﬁcally, the mobile phase consisted of
an acetonitrile phosphate buffer (15–17%), pH 3.0, containing
300 mg/L 5-octylosulfate sodium salt as the ion-pair reagent and
1747D2/D3 agonist reverts stress induced risk-aversion20 mg/L Na2EDTA. Reference standards were prepared in 0.2 N
perchloric acid solution containing 7.9 mM Na2S2O5 and 1.3 mM
Na2EDTA. The working electrode was glassy carbon along with a
reference electrode (Ag/AgCl) and the columns were Thermo
Aquasil C18, 250 mm 4.6 mm, 5 μm (Thermo Electron, Cheshire,
UK). The voltage of the working electrode was set at +800 mV in
the LC4C amperometric detector (Bioanalytical Systems, West
Lafayette, IN, USA) and the ﬂow rate of the LC1150 HPLC pump
(GBC Inc, Braeside, Australia) was set at 1.0 mL/min. Quantiﬁcation
of dopamine was done by comparison of the area under the curve
with that of reference standards using HPLC software (Chromato-
graphy Station for Windows).
2.7. Gene expression measurements by real time
quantitative PCR (RT-qPCR)
RT-qPCR analysis was used to measure the mRNA levels of the
following genes: dopamine receptor D1A (Drd1a), dopamine recep-
tor D2 (Drd2) and dopamine receptor 3 (Drd3). The reference gene
for hypoxanthine guanine phosphoribosyl transferase (Hprt) (acces-
sion number from GenBank: NM_012583) was used as an internal
standard for the normalization of the expression of selected
transcripts, since we have ﬁrst conﬁrmed that its expression is
not inﬂuenced by the experimental conditions. Expression level of
Hprt in terms of CT in OFC in the control was 18.6 and in CUS was
19.3 (t=1.82, P=0.10). Regarding the Insular cortex, the expres-
sion levels were in the control of 18.3 and in CUS 19.3 (t=1.87,
P=0.09).
All accession numbers and primer sequences are available on
request. Total RNA was isolated using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) and reverse transcribed with iScript cDNA
Synthesis Kit for RT-PCR (Bio-Rad, Laboratories, Hercules, CA,
USA). Primers were designed using Primer3 software (Rozen and
Skaletsky, 2000), on the basis of the respective GenBank sequences.
All melting curves exhibited a single sharp peak at the expected
temperature.
2.8. c-fos immunohistochemistry
Animals were sacriﬁced 90 min after the end of the behavioral task
(Leite-Almeida et al., 2014; Morgado et al., 2014) with a sub-lethal
injection with pentobarbital and transcardially perfused with phos-
phate buffer (PBS) followed by 4% paraformaldehyde. Brains were
removed, post-ﬁxed in PFA for 4 h, kept in 8% sucrose at 4 1C and cut
in 50 mm coronal sections. c-fos immunohistochemistry was as
described previously (Morgado et al., 2014) using anti-Fos primary
antibody (1:2000; PC38 Anti-c-Fos (Ab-5), Calbiochem, Darmstadt,
Germany) polyclonal swine anti-rabbit secondary antibody (1:200 in
PBS-T; E0353, DAKO, Glostrup, Denmark), avidin–biotin complex (ABC,
1:200, Vector Laboratories, Burlingame, CA, USA) and 0.0125%
diaminobezidine tetrahydrochloride (DAB; Sigma-Aldrich). All proce-
dures were performed at room temperature.
The number of c-fos positive cells was counted within the
boundaries of the medial prefrontal cortex (prelimbic cortex
(PrL), infralimbic cortex (IL) and cingulate cortex (Cg1)), OFC
(medial (MO), ventral (VO) and lateral (LO) parts), somatosensory
cortex (SSC), motor cortex (MC), insula, dorsal striatum (dorsolat-
eral striatum (DLS) and dorsomedial striatum (DMS)) and nucleus
accumbens (shell (NAcS) and core (NAcC)) as previously described
(Morgado et al., 2014).
2.9. Golgi staining
The day after the last stress exposure, animals from each group
were transcardially perfused with 0.9% saline under deep pento-
barbital anesthesia. Brains were removed and processed for 3Dmorphometric analysis of neurons; brieﬂy, they were immersed in
Golgi-Cox solution for 14 days, then transferred to a 30% sucrose
solution (minimum 3 days) before 200 μm coronal sections were
collected and developed (see Cerqueira et al., 2007c for details).
2.10. Imuno-Golgi staining
To analyze neurons speciﬁcally recruited during the task, a method
that combines c-fos immunohistochemistry with Golgi-impregnation
was performed. Stressed and control rats, 90 min after the end of
the behavioral task, were transcardially perfused with 0.9% saline
under deep pentobarbital anesthesia and processed according to
the protocol described by Pinto et al. (2012) using primary c-fos
antibody (1:1000; Calbiochem), secondary anti-rabbit antibody
Alexa Fluor 594 (1:500; invitrogen) and DAPI (1 mg/ml). Sections
were mounted in superfrost slides using Vectashield mounting
medium (Vector Laboratories).
2.11. Neuronal 3D-dendritic structure analysis
Pyramidal neurons of lateral part of OFC (lOFC) cortex and of insula
(Zilles and Wree, 1995) were analyzed. The criteria used to select
neurons for reconstruction were those described by Uylings et al.
(1986). In order to minimize selection bias, slices containing the
region of interest were randomly searched and the ﬁrst 10 neurons
fulﬁlling the above criteria (maximum of 3 neurons per slice) were
selected. For each selected neuron, all branches of the dendritic
tree were reconstructed at 600 magniﬁcation using a motorized
microscope (Axioplan 2, Carl Zeiss, Germany), attached to a camera
(DXC-390, Sony Corporation, Tokyo, Japan) and Neurolucida soft-
ware (MicroBrightField Bioscience) and analyzed using NeuroEx-
plorer software (MicroBrightField Bioscience).
2.12. Statistical analysis
Data was analyzed using SPSS (version 19.0; IBM). Results are
expressed as group means7SE. Results of the ﬁrst experiment
(Control and stress groups) were compared using Student's t test.
Results of the second experiment (controls and stressed animals
treated or not with quinpirole) were analyzed with a two-way
ANOVA (stressntreatment); individual group comparisons were then
made post hoc using Tukey's honestly signiﬁcant differences test.
For all analyses, differences were considered to be signiﬁcant only
when po0.05.
3. Results
3.1. Efﬁcacy of the stress protocol
Our stress protocol was effective, as revealed by a decreased
body weight gain (Experiment 1: controls: 100.2879.63 g;
stress: 65.93719.13 g; t=5.07, po0.001) and increased corti-
costerone levels (Experiment 1: controls: 59.49711.46 ng/mL;
stress: 154.94723.11 ng/mL; t=3.70, po0.001) of stress
animals compared with controls.
3.1.1. Experiment 1
3.1.1.1. Stress biases decisions to safe options. During
training (done in the neutral condition, before stress
exposure), animals increased the number of completed
trials in each session, inversely decreasing total time spent
to do so; totally completed trials were achieved by all
animals on the 8th day of training (data not shown). On
P. Morgado et al.1748average, animals performing the task chose the safe hole
approximately 20% of the times and any of the four risk
holes 80% of the times. This near-random pattern of
choices, that was established relatively early and main-
tained during the entire protocol (as previously described in
Morgado et al., 2014), suggests that at baseline animals
have no preference for either option.
Compared to handling, exposure to CUS signiﬁcantly
increased preference for safe options in the neutral condi-
tion (controls: 21.0570.25 choices; CUS: 26.4870.84
choices t=6.206, P˂0.05, Figure 2, panel A). More impor-
tantly, this stress-triggered bias toward safe was also
present even in the uncertain/risk favorable paradigm
(controls: 17.8370.51 choices; CUS: 21.7571.02 choices;
t=3.43, P˂0.05) and more evident in the safe-favorable
condition (controls: 24.971.17; choices CUS: 31.8371.04
choices; t=4.03, P˂0.05) (Figure 2, panel A).
3.1.1.2. Stress bias to safer behavior is paralleled by
changes in the orbitofrontal cortex. This stress-induced
altered pattern of choice was accompanied by a distinct
task-triggered c-fos activation pattern. Indeed, previously
chronically stressed animals displayed, after task perfor-
mance, a signiﬁcantly increased activation of the lOFC
(controls: 635738 cells/mm2; CUS: 831760 cells/mm2;Figure 2 Effects of chronic stress on risk-taking behavior. (A) Chr
different protocols tested. *po0.05 vs non-stressed controls. (B) Inc
cortex (OFC) and insular cortex (Ins) in chronically stressed animals
No signiﬁcant differences were found in other brain areas exam
cortex), IL (infralimbic cortex), Cg1 (cingulate cortex), NaccC/S (N
(somatosensory cortex), MC (motor cortex). *po0,05 vs non-stresset=2.32, P˂0.05) and the insula (controls: 205719 cells/
mm2; CUS: 282715 cells/mm2; t=2.50, P˂0.05), but not
any other brain region, when compared to controls (vOFC –
controls: 8737110 cells/mm2; CUS: 981795 cells/mm2;
t=0.74, P=0.48. mOFC – controls: 608768 cells/mm2;
CUS: 694754 cells/mm2; t=0.10, P=0.34. PrL – controls:
543733 cells/mm2; CUS: 510769 cells/mm2; t=0.31,
P=0.76. IL – controls: 544718 cells/mm2; CUS: 459741
cells/mm2; t=1.88, P=0.13. Cg1 – controls: 55777 cells/
mm2; CUS: 39877 cells/mm2; t=1.58, P=0.15. NAcC –
controls: 48175 cells/mm2; CUS: 52978 cells/mm2;
t=0.44, P=0.67. NAcS – controls: 465738 cells/mm2;
CUS: 454753 cells/mm2; t=0.17, P=0.87. DLS – controls:
412742 cells/mm2; CUS: 429741 cells/mm2; t=0.31,
P=0.77. DMS – controls: 427765 cells/mm2; CUS: 452786
cells/mm2; t=0.24, P=0.82. SSC – controls: 241732
cells/mm2; CUS: 207733 cells/mm2; t=0.73, P=0.48. MC
– controls: 273728 cells/mm2; CUS: 213723 cells/mm2;
t=1.60, P=0.15.) (Figure 2, panel B). Of note, as c-fos
induction is relatively fast and transient and animals were
not being stressed/handled for at least 24 h at time of
sacriﬁce, differences in activation pattern most probably
reﬂect a different response to the task rather than a direct
stress effect (Coggeshall, 2005).onic stress signiﬁcantly decreased risk choices among the three
reased (in %) in the density of c-fos positive cells in orbitofrontal
performing the task when compared with non-stressed controls.
ined. L/V/MOFC (lateral/ventral/medial OFC), PrL (prelimbic
acc Core/Shell), DLS/DMS (dorsomedial/lateral striatum), SSC
d controls.
1749D2/D3 agonist reverts stress induced risk-aversionGiven the over-activation observed on orbitofrontal and
insular cortices, we measured DA levels in these regions by
HPLC. Data shows a signiﬁcant decrease of DA levels
immediately after chronic stress (and before behavioral
testing) in the OFC (t=3.32, P˂0.05). In contrast, no
signiﬁcant differences in the levels of this neurotransmitter
were found, at the same timepoint, in the insular cortex
(t=1.30, P=0.24) (Figure 3, panel A).
Given the previous result, we also quantiﬁed the mRNA
levels of the different DA receptors in the OFC and anterior
insula. Immediately after stress, expression levels of the
mRNAs encoding the Drd1 (t=0.04, P=0.97) and Drd3
(0.49, P=0.64) receptors did not differ between controls
and stressed animals. However, there was a signiﬁcant up-
regulation of Drd2 mRNA in this brain region (t=3.42,
P˂0.05) (Figure 3, panel B). No changes on expression levels
of the mRNAs encoding the Drd1 (t=1.39, P=0.21), Drd2
(t=1.70, P=0.14) and Drd3 (t=0.80, P=0.46) were
found among anterior insula (Figure 3, panel B).
Finally, we performed a three-dimensional morphometric
analysis of pyramidal neurons from the lOFC and insula
cortices, immediately after stress. When compared withFigure 3 Neurochemical and neural effects of chronic stress. (A)
cortex (OFC) and insula as compared with non-stressed controls.
Unpredictable Stress on dopamine D1, D2 and D3 receptors mRNA le
when compared with non-stress controls. *po0.05 vs non-stressed c
in the insular pyramidal neurons in animals submitted to chronic stre
analysis of apical and basal dendrites in the OFC pyramidal neurons i
stressed controls. Neurons speciﬁcally recruited by the task were as
stressed controls.controls, chronically stressed animals displayed a signiﬁcant
increase in the length of apical dendrites of OFC neurons
(t=2.96, P˂0.05), while basal dendrites of the OFC and
apical and basal dendrites of the insula were not affected
(Figure 3, panels C and D). To assess whether these changes
were present in the neurons speciﬁcally activated by the
behavioral task, we performed the immuno-Golgi staining in
brains collected 90 min after task completion (24 days after
the last stressor); this approach conﬁrmed our hypothesis, by
revealing a similar decrease in the apical dendrites of lOFC c-
fos positive cells (t=2.60, P˂0.05) (Figure 3, panel D).
3.1.2. Experiment 2
3.1.2.1. D2/D3 agonist quinpirole reverts stress effects on
behavior. Given our observations of a decreased dopamine
content and overexpression of drd2 mRNA in the OFC after
chronic stress, but also previous studies showing the effect
of D2/D3 agonist quinpirole in decision making (Morgado
et al., 2014; St Onge et al., 2010; St Onge and Floresco,
2009; Zeeb et al., 2009), we decided to test its effect on
reward prediction and our risk-based decision-making beha-
vior. Conﬁrming our previous results, chronically stressedThe effects of chronic stress on HPLC DA levels in orbitofrontal
*po0.05 vs non-stressed controls. (B) The effects of Chronic
vels (in %) in orbitofrontal cortex (OFC) and insular cortex (Ins)
ontrols. (C) Morphometric analysis of apical and basal dendrites
ss when compared with non-stressed controls. (D) Morphometric
n animals submitted to chronic stress when compared with non-
sessed with imunoGolgi staining (Golgi+c-fos). *po0.05 vs non-
P. Morgado et al.1750animals displayed an increased preference for safe choices
in all three different paradigms. Interestingly, acute admin-
istration of quinpirole before behavioral testing (during
which animals were not being stressed) completely reverted
that bias making their pattern of choices undistinguishable
from that of untreated controls (neutral: effect of stress –
F(1,42)=11.06, po0.01, effect of quinpirole – F(1,42)=4.02,
p=0.51, interaction – F(1,42)=8.36, po0.01; risk favorable:
effect of stress – F(1,42)=6.59, po0.05, effect of quinpirole
– F(1,42)=3.28, p=0.77, interaction – F(1,42)=4.13, po0.05;
safe favorable: effect of stress – F(1,42)=9.04, po0.01,
effect of quinpirole – F(1,42)=1.64, p=0.27, interaction –
F(1,42)=4.11, po0.05), (Figure 4). Of notice, treatment
with quinpirole had no effect on the choices of non-
stressed animals in any of the paradigms (Figure 4).Figure 4 Quinpirole effects on decision-making. Chronic stress
exposure, as compared with non-stressed controls, signiﬁcantly
increases the frequency of safe choices (in %) in all testing
conditions, an effect that is reverted by D2/D3 agonist quinpir-
ole. Neutral: risky and safe choices associated with the same
reward magnitude in the long run (4 pellets at 25% vs 1 pellet at
100%); risk favorable: risky choices associated with higher
reward magnitude in the long run (8 pellets at 25% vs 1 pellet
at 100%); safe favorable: safe choices associated with higher
reward magnitude in the long run (4 pellets at 25% vs 2 pellets
at 100%). CUS (Chronic Unpredictable Stress); QP (quinpirole).
*po0.05 vs non-stressed controls.4. Discussion
Stress has a strong impact on brain function and could lead
either to beneﬁcial or detrimental effects (McEwen, 1998).
Chronic stress impairs, amongst others, behavioral ﬂexibil-
ity (Cerqueira et al., 2007a), pavlovian to instrumental
transfer (Morgado et al., 2012) and decision-making (Dias-
Ferreira et al., 2009). Surprisingly, however, no study has to
our knowledge explored the impact of chronic stress on the
willingness to take risks, as we have done in the present
work (Morgado et al., 2015). A recent paper by Pabst et al.
(2013) has shown that, in humans, acute stress exposure
before the task increases the preference for risky options,
which can be correlated with an increase in salivary cortisol
reﬂecting the activation of the hypothalamus–pituitary–
adrenal (HPA) axis. Interestingly, these data are in line with
results by Koot et al. (2013) revealing that acute corticos-
terone administration, which partially mimics HPA axis
activation, promotes the choice of unfavorable conditions.
However, both studies seem to be in contradiction with the
present ﬁndings that chronic stress increases the preference
for safe options. These contrasting and opposing effects of
acute versus chronic stress have been described in other
behavioral domains (more importantly in cognition, where
acute stress enhances while chronic stress impairs memory,
see Lupien et al., 2009 for a review) and might represent a
fundamental aspect of the two-facets of the stress
response. Indeed, while acute stress can be considered
adaptive (Diamond et al., 1992), chronic or prolonged stress
becomes maladaptive, in line with its negative impact in
several dimensions of brain function (Sousa and Almeida,
2012), and, as shown herein, also risk preference. In line
with our data, Kandasamy et al. (2014) recently described
that chronic elevation of cortisol levels induced by admin-
istration of hydrocortisone promotes a risk aversive beha-
vior among healthy volunteers.
Despite these considerations, our observations suggest that
animals submitted to chronic stress change their valuating
systems, overrating losses and, subsequently, avoiding ‘risk’
options that imply the possibility of not receiving any reward.
Importantly, the present study also shows, using the expression
of the c-fos protein, that this behavioral effect is associated
with an over-activation of the lateral part of OFC and insular
cortex. Intriguingly, but signiﬁcantly, these are exactly the same
two regions that mediate the effect of acute corticosteroneadministration on a rodent Iowa gambling task described above
(Koot et al., 2013), which strongly suggests these areas to be
key to the impact of stress and glucocorticoids on tasks
involving uncertainty/risk. The OFC is critically involved on
assigning and updating reward values, encoding a wide range of
other variables indispensable for decision-making, including
expected outcomes (Schoenbaum et al., 1998), effort asso-
ciated to each option (Kennerley et al., 2009; Roesch and
Olson, 2005), conﬁdence in the decision (Kepecs et al., 2008)
and the probability of win (Kennerley et al., 2009). Interest-
ingly, rodent lesion studies have highlighted that the OFC
encodes speciﬁc information about the outcome rather than
its general affective value (Burke et al., 2008). Additionally, we
had previously shown that chronic stress biased behavior from
goal-directed to habit based choices, which was mediated by a
shift from an atrophied medial prefrontal loop to a hypertro-
phied orbitofrontal network (Dias-Ferreira et al., 2009). In
accordance to this ﬁnding, we have also identiﬁed a deleterious
impact of chronic stress in pavlovian to instrumental transfer, a
function highly dependent on the integrity of the OFC (Morgado
et al., 2012). Furthermore, the insular cortex was also over-
activated during the task in stressed animals. This brain region
is involved in representations of bodily internal states and needs
(Naqvi and Bechara, 2009) and in risk-aversion signaling (Clarke
et al., 2008; Preuschoff et al., 2008). Insula lesion studies have
shown an increase in risky non-advantageous choices (Clarke
et al., 2008), which is in line with our observation of insular
over-activation associated to a risk-aversion pattern of choice.
Together with hyperactivation of these regions, we found a
stress-induced signiﬁcant reduction of DA in OFC, but not in
the insular cortex, accompanied with overexpression of Drd2
mRNA; this suggests that DA reduction and subsequent
upregulation of Drd2 are implicated in the processes leading
to the observed behavioral changes. This is in line with
previous studies revealing a role for stress-induced hypodopa-
minergic status (in the PFC) in the genesis of working memory
1751D2/D3 agonist reverts stress induced risk-aversion(Mizoguchi et al., 2000) and decision-making deﬁcits (Gruber
et al., 2010; Tseng and O’Donnell, 2004); of notice, the latter
were ascribed to a lack of inhibitory actions of D2 receptors on
NMDA-induced responses (Tseng and O’Donnell, 2004). Irre-
spective of the underlying mechanism, our observation that
the stress-induced bias on risk-based decision-making can be
pharmacologically reverted by a D2/D3 agonist, quinpirole,
clearly conﬁrms the involvement of the dopaminergic system
in this process. These observations are in accordance with the
hypothesis that stress induced hypodopaminergic state could
mediate its behavioral effects on risk-based decision-making
through hyperactivation of OFC. Indeed, two recent studies
pointed out the role of dopaminergic system in stress resi-
lience (Zurawek et al., 2013) and social aversion induced by
chronic stress (Barik et al., 2013). Moreover, the dopaminergic
system has also been implied in the behavioral alterations
induced by acute stress on decision-making paradigms (Shaﬁei
et al., 2012). Interestingly, no changes in insular DA levels
were found, which points to a possible involvement of other
neurotransmitters such as GABA and glutamate in these
processes (de Kloet et al., 2005).
Previous studies have reported effects of dopaminergic
agents on decision-making behaviors, associating dopaminer-
gic agonists with increased rates of risk choices (Morgado
et al., 2014; Riba et al., 2008; St Onge et al., 2010; St Onge
and Floresco, 2009). As chronic stressed animals were risk-
aversive, it could be argued that quinpirole effects observed in
our study could be explained by an unspeciﬁc increasing of
risk-prone behavior induced by dopaminergic activation. How-
ever, if this were true, one would expect that non-stressed
quinpirole-treated animals would also increase their frequency
of risk choices, which was not veriﬁed herein. This absence of
quinpirole effects on control animals contrasts with our prior
observations (Morgado et al., 2014) and points out the
discrepancy between acute (previous study) and chronic
(present work) effects of dopaminergic agents on decision-
making. Indeed, the fact that quinpirole was administered
daily but only the 5 last days of each paradigm were analyzed
allows the dopaminergic system do adapt to increasing D2/D3
stimulation by downregulating receptor expression, for exam-
ple. Additionally, contradictory data on the literature reported
impaired performance on gambling tasks induced by dopami-
nergic agonists (Zeeb et al., 2009) and related lower dopami-
nergic levels with higher risk choices in Iowa Gambling Task
(IGT) (Sevy et al., 2006) supporting the idea that effects of
dopaminergic drugs on decision-making cannot be explained
by an oversimplistic view and could be dependent on basal
levels of DA, available dopaminergic receptors, speciﬁc fea-
tures of decision-making tasks and duration of treatment.
Our results suggest, for the ﬁrst time, that risk-aversion
induced by chronic stress is associated to reduced DA levels in
OFC and that this impairments on decision-making can be
reverted with dopaminergic agents. These ﬁndings are relevant
not only for unveiling speciﬁc mechanisms underlying stress-
induced decision-making impairments but also for proposing a
pharmacological intervention that can reset the valuating
system of stressed individuals. Since decision-making impair-
ments are core symptoms in several neuropsychiatric disorders
such as pathological gambling, obsessive and impulsive dis-
orders, our data support the possibility of alternative patholo-
gical mechanisms that could lead to the development of new
and more effective treatments and interventions.Role of the funding source
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